Evidence map›Paper›PMID 33513669›Full record

ArticleMembranes2021

Polydopamine Functionalized Graphene Oxide as Membrane Nanofiller: Spectral and Structural Studies.

Abedalkader Alkhouzaam, Hazim Qiblawey, Majeda Khraisheh

Abstract read
In one paragraph

Article in Membranes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Enhancement COScientific reports · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Enhancement of AFBBiomolecules · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abedalkader AlkhouzaamDepartment of Chemical Engineering, College of Engineering, Qatar University, P.O. Box 2713 Doha, Qatar.ORCID 0000-0002-3932-0437
Hazim QiblaweyDepartment of Chemical Engineering, College of Engineering, Qatar University, P.O. Box 2713 Doha, Qatar.ORCID 0000-0003-3485-3354
Majeda KhraishehDepartment of Chemical Engineering, College of Engineering, Qatar University, P.O. Box 2713 Doha, Qatar.

Funding

Qatar National Research Fund GSRA4-1-0504-17043
6 · The paper itself

Abstract

High-degree functionalization of graphene oxide (GO) nanoparticles (NPs) using polydopamine (PDA) was conducted to produce polydopamine functionalized graphene oxide nanoparticles (GO-PDA NPs). Aiming to explore their potential use as nanofiller in membrane separation processes, the spectral and structural properties of GO-PDA NPs were comprehensively analyzed. GO NPs were first prepared by the oxidation of graphite via a modified Hummers method. The obtained GO NPs were then functionalized with PDA using a GO:PDA ratio of 1:2 to obtain highly aminated GO NPs. The structural change was evaluated using XRD, FTIR-UATR, Raman spectroscopy, SEM and TEM. Several bands have emerged in the FTIR spectra of GO-PDA attributed to the amine groups of PDA confirming the high functionalization degree of GO NPs. Raman spectra and XRD patterns showed different crystalline structures and defects and higher interlayer spacing of GO-PDA. The change in elemental compositions was confirmed by XPS and CHNSO elemental analysis and showed an emerging N 1s core-level in the GO-PDA survey spectra corresponding to the amine groups of PDA. GO-PDA NPs showed better dispersibility in polar and nonpolar solvents expanding their potential utilization for different purposes. Furthermore, GO and GO-PDA-coated membranes were prepared via pressure-assisted self-assembly technique (PAS) using low concentrations of NPs (1 wt. %). Contact angle measurements showed excellent hydrophilic properties of GO-PDA with an average contact angle of (27.8°).

Indexed as

aminated GOamine-functionalized GOdispersibilitygraphene oxidehydrophilic nanofillerpolydopamine

Identifiers

PMID33513669
PMCPMC7910935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.